AANAT

gene product
SNAT
The protein encoded by this gene belongs to the acetyltransferase superfamily. It is the penultimate enzyme in melatonin synthesis and controls the night/day rhythm in melatonin production in the vertebrate pineal gland. Melatonin is essential for the function of the circadian clock that influences activity and sleep. This enzyme is regulated by cAMP-dependent phosphorylation that promotes its interaction with 14-3-3 proteins and thus protects the enzyme against proteasomal degradation. This gene may contribute to numerous genetic diseases such as delayed sleep phase syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
285 antibodies from 28 providers.

Antibody properties

General

Applications

or Cancel
Antibody
antibodies-online
103 antibodies
Proteintech Group
1 antibody
Abnova Corporation
6 antibodies
Novus Biologicals
5 antibodies
Invitrogen Antibodies
4 antibodies
LifeSpan BioSciences, Inc.
55 antibodies
GeneTex
5 antibodies
OriGene
9 antibodies
Biorbyt
21 antibodies
Boster Biological Technology
1 antibody
NovoPro Bioscience Inc.
2 antibodies
Aviva Systems Biology
1 antibody
NSJ Bioreagents
1 antibody
Acris Antibodies GmbH
6 antibodies
Abgent
1 antibody
Atlas Antibodies
1 antibody
Bioworld Technology, Inc
1 antibody
St John's Laboratory
2 antibodies
Abbexa
8 antibodies
MyBioSource
2 antibodies
Creative Biolabs
2 antibodies
United States Biological
13 antibodies
Creative Diagnostics
2 antibodies
EMD Millipore
2 antibodies
Leading Biology
1 antibody
ProSci
1 antibody
MilliporeSigma / Merck KGaA
2 antibodies